Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) EPS (Basic): 2022-2025

Historic EPS (Basic) for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to -$0.86.

  • Abivax's EPS (Basic) fell 30.25% to -$0.86 in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.40, marking a year-over-year decrease of 70.72%. This contributed to the annual value of -$2.99 for FY2024, which is 18.92% up from last year.
  • As of Q2 2025, Abivax's EPS (Basic) stood at -$0.86, which was up 0.63% from -$0.87 recorded in Q1 2025.
  • Over the past 5 years, Abivax's EPS (Basic) peaked at -$0.00 during Q4 2022, and registered a low of -$0.87 during Q1 2025.
  • Over the past 3 years, Abivax's median EPS (Basic) value was -$0.70 (recorded in 2024), while the average stood at -$0.52.
  • Data for Abivax's EPS (Basic) shows a maximum YoY plummeted of 40.31% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Abivax's EPS (Basic) stood at -$0.00 in 2022, then tumbled by 40.31% to -$0.00 in 2023, then plummeted by 34.66% to -$0.00 in 2024, then slumped by 30.25% to -$0.86 in 2025.
  • Its EPS (Basic) stands at -$0.86 for Q2 2025, versus -$0.87 for Q1 2025 and -$0.00 for Q4 2024.